Youngil Montelukast Tablets 10 mg (Sodium Montelukast)
Montelukast Sodium 10.4mg
Tablet · Prescription medication
Youngil Pharmaceutical Co., Ltd.
MFDS item code 202003048 · Approved 2020.04.27
This product's status changed to Expired on 2025.04.27. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Prevention and treatment of asthma; relief of seasonal and perennial allergic rhinitis symptoms
This medication helps in preventing and continuously treating asthma. It is also used to alleviate symptoms of seasonal and perennial allergic rhinitis.
Take this medicine once daily. Patients with asthma should take it in the evening; for patients with allergic rhinitis, the administration time should be determined according to the patient’s condition. Patients with both asthma and allergic rhinitis should take 1 tablet, 1 sachet, or 1 strip once daily in the evening. Adults and adolescents aged 15 years and older: Administer 10 mg of montelukast orally once daily. Adults and adolescents aged 15 years and older: Place 10 mg of montelukast on the tongue once daily and allow it to dissolve; take without water.
Children aged 6~14 years: Chew and take 5 mg of montelukast once daily. Administer this medicine 1 hour before or 2 hours after a meal. Children aged 2~5 years: Chew and take 4 mg of montelukast once daily. Administer this medicine 1 hour before or 2 hours after a meal. Children aged 6~14 years: Place 5 mg of montelukast on the tongue once daily and, once it has disintegrated, take without water. Administer this medicine 1 hour before or 2 hours after a meal. Children aged 2~5 years: Place 4 mg of montelukast on the tongue once daily and, once it has disintegrated, take without water. Administer this medicine 1 hour before or 2 hours after a meal. Children aged 6~14 years: Place 5 mg of montelukast on the tongue once daily and allow it to dissolve; take without water. Administer this medicine 1 hour before or 2 hours after a meal. Children aged 2~5 years: Place 4 mg of montelukast on the tongue once daily and allow it to dissolve; take without water. Administer this medicine 1 hour before or 2 hours after a meal. Children aged 6~14 years: Administer 5mg of montelukast orally once daily. Administer this medicine 1 hour before or 2 hours after a meal. Asthma — Children aged 2~5 years: Administer 4 mg of montelukast orally once daily. Asthma — Infants aged 12 months~under 2 years: Administer 4 mg of this medicine orally once daily in the evening. Asthma — Efficacy and safety have not been established for asthma in infants under 12 months of age. Allergic rhinitis — Children aged 2~5 years: Administer 4 mg of montelukast orally once daily. Allergic rhinitis — Efficacy and safety have not been established for seasonal allergic rhinitis in infants under 2 years of age. Allergic rhinitis — Infants aged 6 months~under 2 years: Administer 4mg of this medicine orally once daily. Allergic rhinitis — Efficacy and safety have not been established for perennial allergic rhinitis in infants under 6 months of age.
This medication contains the artificial sweetener aspartame, and patients with the genetic disorder phenylketonuria should avoid use. Caution should be taken not to exceed the daily allowable dosage of aspartame, which can be taken up to a maximum of 2.4 grams for adults. Patients who are allergic to this medication or its components should not use it. Additionally, this drug contains lactose, thus patients with lactose intolerance or certain genetic issues should avoid use. This medication is used to treat asthma or allergic rhinitis, and various side effects such as fatigue, headache, abdominal pain, fever, cough, and rash have been reported in clinical trials among some patients. Special caution is necessary when prescribing to certain age groups or conditions such as children, elderly individuals, and pregnant women. This medication is ineffective during acute asthma attacks, so emergency bronchodilators should always be on hand. Patients should not suddenly discontinue or reduce the dosage of other asthma treatments while taking this medication, and should follow the physician's instructions. Patients with hypersensitivity to aspirin should not take aspirin or non-steroidal anti-inflammatory drugs while on this medication. Rarely, severe symptoms such as vasculitis or eosinophilia may develop after taking this medicine, so individuals should consult with healthcare professionals if any unusual symptoms occur. This medication has not reported significant interactions with many other drugs, but monitoring by a physician may be necessary when taken with certain medications. Women who are pregnant or breastfeeding should only take this medication after consulting their physician, and should only use it if necessary. This medication has been proven safe and effective across a wide age range from children to adults, but safety has not been established for children under 6 months of age. In the case of overdose, there are no specific antidotes, and general symptomatic treatment should be followed under a physician's guidance. When storing, keep this medication in a sealed container, away from children, and protect it from direct sunlight. After opening, it is advisable to take it quickly. If symptoms related to the nervous system or other abnormal symptoms occur during use, inform medical personnel immediately.
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to air, moisture, and light and should be stored in a sealed container. Additionally, it is best to store at room temperature between 1 and 30 degrees Celsius.
Beige colored, rounded square film-coated tablets
30 tablets/box [(10 tablets/PTP x 3)], 28 tablets/box [(7 tablets/PTP x 4)]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Montelukast Sodium 10.4mg
Tablet · Prescription medication
Youngil Pharmaceutical Co., Ltd.

Montelukast Sodium 5.2mg
Chewable Tablet · Prescription medication
Korea Organon Co., Ltd.

Montelukast Sodium 10.4mg
Tablet · Prescription medication
Korea Organon Co., Ltd.

Montelukast Sodium 4.16mg
Chewable Tablet · Prescription medication
Korea Organon Co., Ltd.
Montelukast Sodium 4.16mg
Prescription medication
Korea Organon Co., Ltd.

Montelukast Sodium 10.4mg
Tablet · Prescription medication
JW Pharmaceutical Co., Ltd.

Montelukast Sodium 4.16mg
Chewable Tablet · Prescription medication
Youngjin Pharmaceutical Co., Ltd.

Montelukast Sodium 4.16mg
Chewable Tablet · Prescription medication
Samil Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.